Shionogi & Co., Ltd. - Product Pipeline Review - 2013

Publisher Name :
Date: 31-Jul-2013
No. of pages: 78
Inquire Before Buying

Shionogi & Co., Ltd. - Product Pipeline Review - 2013

Summary

Global Markets Direct's pharmaceuticals report, "Shionogi & Co., Ltd. - Product Pipeline Review - 2013" provides data on the Shionogi & Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Shionogi & Co., Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Shionogi & Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Shionogi & Co., Ltd. - Brief Shionogi & Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.

- Review of current pipeline of Shionogi & Co., Ltd. human therapeutic division.

- Overview of pipeline therapeutics across various therapy areas.

- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

- Product profiles for late stage and clinical stage products of Shionogi & Co., Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.

- Recent updates of the Shionogi & Co., Ltd.'s pipeline in the last quarter.

- Key discontinued and dormant projects.

- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Shionogi & Co., Ltd.'s strategic position with total access to detailed information on its product pipeline.

- Assess the growth potential of Shionogi & Co., Ltd. in its therapy areas of focus.

- Identify new drug targets and therapeutic classes in the Shionogi & Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

- Exploit collaboration and partnership opportunities with Shionogi & Co., Ltd..

- Avoid Intellectual Property Rights related issues.

- Explore the dormant and discontinued projects of Shionogi & Co., Ltd. and identify potential opportunities in those areas.

Shionogi & Co., Ltd. - Product Pipeline Review - 2013

Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 7
Shionogi & Co., Ltd. Snapshot 8
Shionogi & Co., Ltd. Overview 8
Key Information 8
Key Facts 8
Shionogi & Co., Ltd. - Research and Development Overview 9
Key Therapeutic Areas 9
Shionogi & Co., Ltd. - Pipeline Review 14
Pipeline Products by Stage of Development 14
Pipeline Products - Monotherapy 15
Pipeline Products - Combination Treatment Modalities 16
Shionogi & Co., Ltd. - Pipeline Products Glance 17
Shionogi & Co., Ltd. - Late Stage Pipeline 17
Phase III Products/Combination Treatment Modalities 17
Shionogi & Co., Ltd. Clinical Stage Pipeline Products 18
Phase II Products/Combination Treatment Modalities 18
Phase I Products/Combination Treatment Modalities 19
Shionogi & Co., Ltd. - Early Stage Pipeline Products 20
Preclinical Products/Combination Treatment Modalities 20
Discovery Products/Combination Treatment Modalities 21
Shionogi & Co., Ltd. - Drug Profiles 22
(irbesartan + trichlormethiazide) 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
(lidocaine + prilocaine) 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
39-f 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Actair 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Benzimidazole Derivative 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Beta-Secretase Inhibitor 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Compound-18e 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
doripenem 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
duloxetine hydrochloride DR 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
guanfacine hydrochloride ER 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
interferon gamma-1a 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Japanese Cedar Pollen Tablet 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
lisdexamfetamine dimesylate 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
lusutrombopag 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
naldemedine 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
ospemifene 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
oxycodone hydrochloride 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
P2X3 Receptor Antagonist 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Peptide Cocktail Vaccine 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
prednisolone acetate 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
S-117957 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
S-120083 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
S-222611 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
S-234462 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
S-288310 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
S-488210 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
S-488410 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
S-555739 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
S-556971 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
S-646240 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
S-649266 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
S-707106 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
velneperit 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Shionogi & Co., Ltd. - Pipeline Analysis 55
Shionogi & Co., Ltd. - Pipeline Products by Therapeutic Class 55
Shionogi & Co., Ltd. - Pipeline Products By Target 59
Shionogi & Co., Ltd. - Pipeline Products by Route of Administration 60
Shionogi & Co., Ltd. - Pipeline Products By Mechanism of Action 61
Shionogi & Co., Ltd. - Recent Pipeline Updates 63
Shionogi & Co., Ltd. - Dormant Projects 69
Shionogi & Co., Ltd. - Discontinued Pipeline Products 70
Discontinued Pipeline Product Profiles 70
ADX-415 70
clonidine hydrochloride 70
doripenem 70
lusutrombopag 71
S-444823 71
S-5751 71
S-777469 71
S-8510 71
teceleukin 72
velneperit 72
Shionogi & Co., Ltd. - Company Statement 73
Shionogi & Co., Ltd. - Locations And Subsidiaries 74
Head Office 74
Other Locations & Subsidiaries 74
Shionogi & Co., Ltd. - Key Manufacturing Facilities 76
Appendix 77
Methodology 77
Coverage 77
Secondary Research 77
Primary Research 77
Expert Panel Validation 77
Contact Us 78
Disclaimer 78

List of Tables
Shionogi & Co., Ltd., Key Information 8
Shionogi & Co., Ltd., Key Facts 8
Shionogi & Co., Ltd. - Pipeline by Indication, 2013 12
Shionogi & Co., Ltd. - Pipeline by Stage of Development, 2013 14
Shionogi & Co., Ltd. - Monotherapy Products in Pipeline, 2013 15
Shionogi & Co., Ltd. - Combination Treatment Modalities in Pipeline, 2013 16
Shionogi & Co., Ltd. - Phase III, 2013 17
Shionogi & Co., Ltd. - Phase II, 2013 18
Shionogi & Co., Ltd. - Phase I, 2013 19
Shionogi & Co., Ltd. - Preclinical, 2013 20
Shionogi & Co., Ltd. - Discovery, 2013 21
Shionogi & Co., Ltd. - Pipeline By Therapeutic Class, 2013 56
Shionogi & Co., Ltd. - Pipeline By Target, 2013 59
Shionogi & Co., Ltd. - Pipeline By Route of Administration, 2013 60
Shionogi & Co., Ltd. - Pipeline Products By Mechanism of Action, 2013 61
Shionogi & Co., Ltd. - Recent Pipeline Updates, 2013 63
Shionogi & Co., Ltd. - Dormant Developmental Projects,2013 69
Shionogi & Co., Ltd. - Discontinued Pipeline Products, 2013 70
Shionogi & Co., Ltd., Other Locations 74
Shionogi & Co., Ltd., Subsidiaries 75
Shionogi & Co., Ltd., Key Manufacturing Facilities 76

List of Figures
Shionogi & Co., Ltd. - Pipeline by Indication, 2013 11
Shionogi & Co., Ltd. - Pipeline by Stage of Development, 2013 14
Shionogi & Co., Ltd. - Monotherapy Products in Pipeline, 2013 15
Shionogi & Co., Ltd. - Combination Treatment Modalities in Pipeline, 2013 16
Shionogi & Co., Ltd. - Pipeline By Therapeutic Class, 2013 55
Shionogi & Co., Ltd. - Pipeline By Route of Administration, 2013 60
Shionogi & Co., Ltd. - Pipeline Products By Mechanism of Action, 2013 61
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Siemens Adds To the Growth of Wind Power Generation Market
    Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Current State of Blood Banking Market, Products, Technologies and Services
    The global blood banking and blood products market is expected to reach US$41.9 billion by 2020 with USA continuing to be the largest market worldwide. Asia-Pacific follows a close second with a projected CAGR of 9.1% during this period owing to the refining healthcare infrastructure and increase in the per capita healthcare expenditure. The major [...]
  • Global Human Albumin Market Professional Survey Report 2016
    Published: 23-Aug-2016        Price: US 3500 Onwards        Pages: 110
    Notes: Production, means the output of Human Albumin Revenue, means the sales value of Human Albumin This report studies Human Albumin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share fo......
  • Europe Blood Transfusion Market Report 2021
    Published: 23-Aug-2016        Price: US 4900 Onwards        Pages: 102
    This report studies sales (consumption) of Blood Transfusion in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - BD - B.Braun - TERUMO - Grifols - Fresenius Kabi - GAMA GROUP - Welford Manufacturing - Helm Medical - Vogt Medical - JMS Co. - Wego - Su......
  • Global Liquid-oral Osmotic Pump Industry 2016 Market Research Report
    Published: 22-Aug-2016        Price: US 2800 Onwards        Pages: 152
    The Global Liquid-oral Osmotic Pump Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Liquid-oral Osmotic Pump industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Liquid-oral Osmotic Pump market analysis is provided for the international market including development history, competitive landscape analysis, and major regions'......
  • Global Collagen Sales Market Report 2021
    Published: 22-Aug-2016        Price: US 4000 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Collagen Revenue, means the sales value of Collagen This report studies sales (consumption) of Collagen in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - 3DM, Inc. (3D-Matrix, Ltd.) - Actamax Surgical Materials, LLC - Adhesys......
  • Global Fibrin Sealants Sales Market Report 2021
    Published: 22-Aug-2016        Price: US 4000 Onwards        Pages: 108
    Notes: Sales, means the sales volume of Fibrin Sealants Revenue, means the sales value of Fibrin Sealants This report studies sales (consumption) of Fibrin Sealants in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - 3DM, Inc. (3D-Matrix, Ltd.) - Actamax Surgical Materials,......
  • China Biotech API Industry 2016 Market Research Report
    Published: 22-Aug-2016        Price: US 3200 Onwards        Pages: 138
    The China Biotech API Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Biotech API industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biotech API market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and......
  • Global Hydrogel Sales Market Report 2021
    Published: 18-Aug-2016        Price: US 4000 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Hydrogel Revenue, means the sales value of Hydrogel This report studies sales (consumption) of Hydrogel in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - 3M - Alliqua BioMedical - Ocular Therapeutix - Axelgaard ......
  • Global Thyme Essential Oil Market Professional Survey Report 2016
    Published: 18-Aug-2016        Price: US 3500 Onwards        Pages: 115
    Notes: Production, means the output of Thyme Essential Oil Revenue, means the sales value of Thyme Essential Oil This report studies Thyme Essential Oil in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue a......
  • 2016 Bifonazole (CAS 60628-96-8) Industry Market Report
    Published: 17-Aug-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Bifonazole Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Bifonazole industry with a focus on the Chinese market. The report provides key statistics on the market status of the Bifonazole manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applicati......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs